Exapine Pre-Filled Syringes 20 mg/0.2 ml Pre-Filled Syringes 40 mg/0.4 ml Pre-Filled Syringes 60 mg/0.6 ml Pre-Filled Syringes 80 mg/0.8 ml

The Active Pharmaceutical ingredients is (Enoxaparin Sodium).

Quote

The First generic biological product registered in Egyptian Market and Africa concerning the (Enoxaparin Sodium).

Exapine is Manufactured on the Prefilled Syringes dedicated and sterile rare line from the scratch till the release of the finished product.

Exapine Batches are all released and approved By EDA and NORCB to Egyptian market after fulfilling all the requirements and regulations for the registration of the biological products regarding the NRA.

Exapine is a life saving product, and the importance of Exapine increased due to the Pandemic waves of Covid 19.

Exapine is indicated as a Prophylaxis of venous thromboembolic disease in moderate and high-risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery.

Exapine is indicated as a Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism.

Exapine is indicated as Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), excluding PE likely to require thrombolytic therapy or surgery.

Exapine is indicated as Prevention of thrombus formation in extracorporeal circulation during hemodialysis.

Exapine is indicated for Acute coronary syndrome, Treatment of unstable angina and Non-ST-segment Elevation Myocardial Infarction (NSTEMI), in combination with oral acetylsalicylic acid.

Exapine is indicated for Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).

Exapine is administered as S.C. injection & IV (Bolus)Injection for acute STEMI indication only.

Exapine is supplied to local Market and institutes with a reasonable price that can be afforded with the Egyptian patient.